10x Genomics Inc. - notizie pubblicate 228 - letture 8.449
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.07 submission of matters to a vote of security holders the annual meeting of stockholders of 10x genomics, inc. (the "company") was held on june 11, 2024, via live ...
10X GENOMICS INC.
Additional Proxy Soliciting Materials - Form DEFA14A
Document united states securities and exchange commission washington, d.c. 20549 ______________________ schedule 14a proxy statement pursuant to section 14(a) of the securities exc ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
New xenium prime 5k pan-tissue and pathways panel increases plex by an order of magnitude and delivers industry-leading speed and throughput pleasanton, calif., may 29, 2024/prnews ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
Pleasanton, calif., may 2, 2024/prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, today announced that members of its management team wi ...
10X GENOMICS INC.
First Quarter 2024 Prepared Remarks
Q1 2024 earnings call prepared remarks april 30, 2024 cassie corneau director, head of investor relations and strategic finance thank you and good afternoon everyone. earlier today ...
10X GENOMICS INC.
10x Genomics Reports First Quarter 2024 Financial Results
Pleasanton, calif., april 30, 2024/prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, today reported financial results for the first quar ...
10X GENOMICS INC.
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
Txg-20240331 table of contents united states securities and exchange commission washington, d.c. 20549 _____________________ form 10-q _____________________ (mark one) ☒ quarterl ...
10X GENOMICS INC.
10x Genomics Reports First Quarter 2024 Financial Results - Form 8-K
10x genomics reports first quarter 2024 financial results pleasanton, calif. april 30, 2024 - 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, today r ...
10X GENOMICS INC.
First Quarter 2024 Press Release
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer 10x genomics inc. pu ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti